RS51536B - Poboljšana bakterijska vakcina mycoplasma hyopneumoniae - Google Patents

Poboljšana bakterijska vakcina mycoplasma hyopneumoniae

Info

Publication number
RS51536B
RS51536B YUP-493/03A YUP49303A RS51536B RS 51536 B RS51536 B RS 51536B YU P49303 A YUP49303 A YU P49303A RS 51536 B RS51536 B RS 51536B
Authority
RS
Serbia
Prior art keywords
mycoplasma hyopneumoniae
vaccine
hyopneumoniae bacterin
mixture
bacterin vaccine
Prior art date
Application number
YUP-493/03A
Other languages
English (en)
Inventor
Hsien-Jue Chu (Steve)
Wumin Li
Zhichang Xu
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22972978&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS51536(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth filed Critical Wyeth
Publication of YU49303A publication Critical patent/YU49303A/sh
Publication of RS51536B publication Critical patent/RS51536B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Kompozicija vakcine za imunizaciju životinja protiv infekcije Mycoplasma hyopneumoniae, naznačena time, što uključuje imunizirajuću količinu bakterina Mycoplasma hyopneumoniae;smešu pomoćnih sredstava koju čine polimer akrilne kiseline i smeša metaboličnog ulja i polioksietilen-polioksipropilen blok kopolimera; ifarmaceutski prihvatljiv nosač, gde kompozicija vakcine posle jednog davanja izaziva zaštitni imunitet od Mycoplasma hyopneumoniae.Prijava sadrži još 17 patentnih zahteva.
YUP-493/03A 2000-12-19 2001-12-11 Poboljšana bakterijska vakcina mycoplasma hyopneumoniae RS51536B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25663700P 2000-12-19 2000-12-19
PCT/US2001/047865 WO2002049666A2 (en) 2000-12-19 2001-12-11 Mycoplasma hyopneumoniae bacterin vaccine

Publications (2)

Publication Number Publication Date
YU49303A YU49303A (sh) 2006-08-17
RS51536B true RS51536B (sr) 2011-06-30

Family

ID=22972978

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-493/03A RS51536B (sr) 2000-12-19 2001-12-11 Poboljšana bakterijska vakcina mycoplasma hyopneumoniae

Country Status (28)

Country Link
US (4) US20020131980A1 (sr)
EP (1) EP1343525B1 (sr)
JP (2) JP5074656B2 (sr)
KR (1) KR100874119B1 (sr)
CN (1) CN1296095C (sr)
AR (1) AR033410A1 (sr)
AT (1) ATE359813T1 (sr)
AU (2) AU2899302A (sr)
BG (1) BG66213B1 (sr)
BR (1) BRPI0116249B1 (sr)
CY (1) CY1106669T1 (sr)
CZ (1) CZ307075B6 (sr)
DE (1) DE60127994T2 (sr)
DK (1) DK1343525T3 (sr)
ES (1) ES2283452T3 (sr)
HK (1) HK1056513A1 (sr)
HR (1) HRP20030585B1 (sr)
HU (1) HU227431B1 (sr)
ME (1) ME00570A (sr)
MX (1) MXPA03005357A (sr)
MY (1) MY129765A (sr)
NZ (1) NZ526904A (sr)
PL (1) PL211174B1 (sr)
PT (1) PT1343525E (sr)
RS (1) RS51536B (sr)
TW (1) TWI308872B (sr)
WO (1) WO2002049666A2 (sr)
ZA (1) ZA200305545B (sr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
GB0400264D0 (en) * 2004-01-07 2004-02-11 Polytherics Ltd Complexes
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
WO2007094893A2 (en) 2005-12-29 2007-08-23 Boehringer Ingelheim Vetmedica, Inc. Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
RU2488407C2 (ru) 2005-12-29 2013-07-27 Берингер Ингельхайм Ветмедика, Инк. Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
PL2094872T5 (pl) 2006-12-15 2020-10-05 Boehringer Ingelheim Animal Health USA Inc. Leczenie świń seropozytywnych wobec przeciwciała anty-pcv2 antygenem pcv2
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
DK2217271T3 (en) 2007-11-06 2016-06-06 Zoetis Services Llc Avirulent, live vaccine with adjuvant against Mycoplasma hyopneumoniae
CA2712006A1 (en) 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
US8444989B1 (en) 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
KR101627879B1 (ko) * 2008-06-25 2016-06-07 브라아쉬 바이오테크 엘엘씨 강화된 소마토스타틴 면역성을 위한 조성물 및 방법
AU2010251761B2 (en) * 2009-05-19 2014-10-09 Bioproperties Pty Ltd A temperature sensitive vaccine strain of Mycoplasma hyopneumoniae and uses thereof
TWI583403B (zh) 2009-06-04 2017-05-21 國立感染症研究所 黴漿菌感染症用疫苗
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
AU2010292233B2 (en) * 2009-09-10 2014-03-06 Boehringer Ingelheim Animal Health USA Inc. New vaccine formulations comprising saponin-containing adjuvants
CN102869379B (zh) 2010-04-30 2015-04-15 淡马锡生命科学研究院有限公司 H5n1谱系的通用疫苗
WO2013149017A1 (en) * 2012-03-28 2013-10-03 Kansas State University Research Foundation Vaccine adjuvant
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
CN103623400B (zh) * 2012-08-24 2016-08-17 普莱柯生物工程股份有限公司 抗猪支原体肺炎、传染性胸膜肺炎疫苗组合物及制备方法
UA121097C2 (uk) * 2012-12-28 2020-04-10 Бьорінгер Інгельхайм Ветмедіка Гмбх Імуногенна композиція, що містить антигени мікоплазм
AU2013370983B2 (en) 2012-12-28 2019-09-26 Boehringer Ingelheim Vetmedica Gmbh Method of making a mycoplasma vaccine
CN104338128B (zh) * 2013-07-31 2017-09-05 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
CN105658660A (zh) 2013-10-02 2016-06-08 勃林格殷格翰动物保健公司 Pcv2 orf2蛋白变体和由其组成的病毒样颗粒
US11883476B2 (en) * 2017-12-04 2024-01-30 Intervet Inc. Canine lyme disease vaccine
CN108324941A (zh) * 2018-04-03 2018-07-27 林淑卿 猪疾病疫苗用佐剂及其制备方法
CN117100851A (zh) * 2023-10-23 2023-11-24 成都依思康生物科技有限公司 一种佐剂、疫苗组合物及其制备方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) * 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US3790665A (en) * 1968-02-23 1974-02-05 Haver Lockhart Labor Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
CA1267087A (en) * 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen
DE3875762T2 (de) 1987-03-17 1993-05-13 Akzo Nv Adjuvanzienmischung.
CA1338618C (en) * 1987-11-03 1996-10-01 Noelene E. Byars Vaccine adjuvant
US5240706A (en) * 1989-04-07 1993-08-31 Ml Technology Ventures, L.P. Intranasal administration of Mycoplasma hyopneumoniae antigen
WO1991018627A1 (en) 1990-05-29 1991-12-12 Smithkline Beecham Corporation Swine pneumonia vaccine and method for the preparation thereof
US6113916A (en) * 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
US5695769A (en) * 1990-06-13 1997-12-09 Pfizer Inc. Pasteurella multocida toxoid vaccines
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
ES2194841T3 (es) 1991-11-15 2003-12-01 Pfizer Procedimiento de produccion de vacunas bacterianas gram negativas.
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5534256A (en) * 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
JP3265095B2 (ja) * 1993-11-19 2002-03-11 本田技研工業株式会社 キャニスタ
BR9507717A (pt) * 1994-05-10 1997-09-23 American Home Prod Vacina brsv viva modificada aperfeiçoada
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
DE19601754A1 (de) * 1996-01-19 1997-07-24 Hoechst Ag Dictyocaulus viviparus Antigen zur Diagnose des Lungenwurmbefalls und zur Vakzinierung
US5846735A (en) * 1996-04-18 1998-12-08 University Of Iowa Research Foundation Hepatitis C virus Fc-binding function
BR9714160A (pt) * 1996-12-20 2000-05-02 Univ Texas Antìgenos uspa1 e uspa2 de moraxella catarrhalis
FR2775601B1 (fr) * 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
US6342231B1 (en) * 1998-07-01 2002-01-29 Akzo Nobel N.V. Haemophilus parasuis vaccine and diagnostic
US6632439B2 (en) * 1999-09-29 2003-10-14 Novartis Animal Health, Inc. Fusobacterium necrophorum vaccine and method for making such vaccine
US6585981B1 (en) 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
JP2005515162A (ja) * 2001-07-02 2005-05-26 ファイザー・プロダクツ・インク マイコプラズマ・ハイオニューモニエ（Ｍｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅ）を用いた単回ワクチン接種
WO2003074026A1 (en) * 2002-03-07 2003-09-12 Biocompatibles Uk Limited Drug carriers comprising amphiphilic block copolymers
ITMI20030269A1 (it) * 2003-02-14 2004-08-15 Advance Holdings Ltd Sale di cetilpiridino di un agente antiinfiammatorio
US8052762B1 (en) * 2010-09-02 2011-11-08 Kelly Van Gogh, LLC Compositions for dyeing keratin-containing fibers

Also Published As

Publication number Publication date
PL363220A1 (en) 2004-11-15
JP5074656B2 (ja) 2012-11-14
WO2002049666A2 (en) 2002-06-27
ME00570B (me) 2011-12-20
ME00570A (en) 2011-12-20
US8187588B2 (en) 2012-05-29
DE60127994T2 (de) 2008-01-17
EP1343525B1 (en) 2007-04-18
HU227431B1 (en) 2011-06-28
MXPA03005357A (es) 2003-10-06
US20070020296A1 (en) 2007-01-25
BR0116249A (pt) 2004-03-02
CN1296095C (zh) 2007-01-24
EP1343525A2 (en) 2003-09-17
KR20030065556A (ko) 2003-08-06
DE60127994D1 (de) 2007-05-31
DK1343525T3 (da) 2007-06-04
BG107898A (bg) 2004-08-31
ZA200305545B (en) 2004-10-18
CY1106669T1 (el) 2012-05-23
AU2899302A (en) 2002-07-01
PL211174B1 (pl) 2012-04-30
US7666439B2 (en) 2010-02-23
WO2002049666A3 (en) 2003-02-06
AU2002228993B2 (en) 2006-06-29
CZ307075B6 (cs) 2018-01-03
HK1056513A1 (en) 2004-02-20
NZ526904A (en) 2005-07-29
JP2009073855A (ja) 2009-04-09
KR100874119B1 (ko) 2008-12-15
ATE359813T1 (de) 2007-05-15
AR033410A1 (es) 2003-12-17
YU49303A (sh) 2006-08-17
BRPI0116249B1 (pt) 2016-06-14
US20100119471A1 (en) 2010-05-13
HUP0400687A3 (en) 2004-10-28
CZ20031721A3 (cs) 2004-04-14
BG66213B1 (bg) 2012-05-31
HRP20030585A2 (en) 2005-06-30
US9238065B2 (en) 2016-01-19
ES2283452T3 (es) 2007-11-01
JP2004518655A (ja) 2004-06-24
CN1489472A (zh) 2004-04-14
HUP0400687A2 (hu) 2004-06-28
HRP20030585B1 (en) 2008-03-31
US20120213816A1 (en) 2012-08-23
TWI308872B (en) 2009-04-21
MY129765A (en) 2007-04-30
PT1343525E (pt) 2007-07-12
US20020131980A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
RS51536B (sr) Poboljšana bakterijska vakcina mycoplasma hyopneumoniae
RS54390B1 (sr) Kombinovana vakcina protiv mycoplasma hyopneumoniae i svinjskog cirkovirusa
DK1187629T3 (da) Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
DE69125842D1 (de) Inaktiviertes mycoplasma hypopneumoniae bacterin und verfahren zu dessen anwendung
IS7076A (is) Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni
MA27265A1 (fr) Formulations d'agoniste opioide a antagoniste liberable et sequestre
ATE472551T1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
DK1061900T3 (da) Dermale præparater
SE0300010D0 (sv) Novel Compounds
BR0214199A (pt) Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
ES2158108T3 (es) Vacunacion in ovo contra la coccidiosis.
EA200300183A1 (ru) Новое сочетание агониста (5-th2) и антагониста (5-ht6) серотонина в качестве фармацевтической композиции
DE69731882D1 (de) Transdermal verabreichtes dextromethorphan als hustenmittel
ATE194753T1 (de) Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonist
ES2185153T3 (es) Uso de mefloquina(+) para el tratamiento de la malaria.
DK1091733T3 (da) (-)-Pseudoephedrin som et sympatomimetisk lægemiddel
IL139601A0 (en) Compositions and methods of modulating an immune response to an antigen
DK1187611T3 (da) Oftalmiske histaminholdige sammensætninger og anvendelse deraf
DK1017822T3 (da) LKTA-deletionsmutant af P. haemolytica
DK0682950T3 (da) Slimhindeadministration af pneumokok-antigener
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
WO2004006851A3 (en) Mycoplasma gallisepticum formulation
SE9802209D0 (sv) Novel compounds
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion